End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.89 EGP | +2.48% | +9.47% | -7.96% |
Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Sales 2024 * | 36.64B 757M | Sales 2025 * | 44.09B 911M | Capitalization | 2.91B 60.19M |
---|---|---|---|---|---|
Net income 2024 * | 417M 8.62M | Net income 2025 * | 417M 8.62M | EV / Sales 2024 * | 0.18 x |
Net Debt 2024 * | 3.65B 75.39M | Net Debt 2025 * | 3.56B 73.59M | EV / Sales 2025 * | 0.15 x |
P/E ratio 2024 * |
9.63
x | P/E ratio 2025 * |
7.51
x | Employees | 5,500 |
Yield 2024 * |
1.35% | Yield 2025 * |
2.68% | Free-Float | 62.18% |
1 day | +2.48% | ||
1 week | +9.47% | ||
Current month | +20.92% | ||
1 month | -0.69% | ||
3 months | -15.99% | ||
6 months | +48.13% | ||
Current year | -7.96% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 2.89 | +2.48% | 15,640,140 |
24-04-16 | 2.82 | +0.36% | 9,879,665 |
24-04-15 | 2.81 | +6.44% | 19,947,530 |
End-of-day quote Egyptian Exchange, April 16, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.96% | 60.07M | |
-32.48% | 15.21B | |
-40.41% | 9.41B | |
-8.71% | 6.23B | |
+5.64% | 5.91B | |
-37.03% | 5.42B | |
+2.92% | 4.89B | |
+49.84% | 4.27B | |
-14.64% | 3.51B | |
-12.53% | 3.43B |
- Stock Market
- Equities
- ISPH Stock